These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7527933)

  • 1. The influence of branched polypeptide carriers on the immunogenicity of predicted epitopes of HSV-1 glycoprotein D.
    Hilbert A; Hudecz F; Mezô G; Mucsi I; Kajtár J; Kurucz I; Gergely J; Rajnavölgyi E
    Scand J Immunol; 1994 Dec; 40(6):609-17. PubMed ID: 7527933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of the 273-284 region of HSV glycoprotein D by synthetic branched polypeptide carrier conjugates.
    Hudecz F; Hilbert A; Mezö G; Mucsi I; Kajtár J; Bösze S; Kurucz I; Rajnavölgyi E
    Pept Res; 1993; 6(5):263-71. PubMed ID: 7504960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide based vaccine design: synthesis and immunological characterization of branched polypeptide conjugates comprising the 276-284 immunodominant epitope of HSV-1 glycoprotein D.
    Mezo G; Dalmadi B; Mucsi I; Bosze S; Rajnavölgyl E; Hudecz F
    J Pept Sci; 2002 Mar; 8(3):107-17. PubMed ID: 11931583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characteristics influencing the carrier function of synthetic branched polypeptides based on poly[Lys-(DL-Ala)3)]backbone.
    Rajnavölgyi E; Lányi A; Hudecz F; Kurucz I; Kiss K; László G; Szekerke M; Gergely J
    Mol Immunol; 1989 Oct; 26(10):949-58. PubMed ID: 2594015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII.
    Mezö G; de Oliveira E; Krikorian D; Feijlbrief M; Jakab A; Tsikaris V; Sakarellos C; Welling-Wester S; Andreu D; Hudecz F
    Bioconjug Chem; 2003; 14(6):1260-9. PubMed ID: 14624643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
    BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
    J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2.
    Grabowska AM; Jennings R; Laing P; Darsley M; Jameson CL; Swift L; Irving WL
    Virology; 2000 Mar; 269(1):47-53. PubMed ID: 10725197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of immunogenicity and antibody recognition of B-cell epitopes by synthetic branched chain polypeptide carriers with poly[L-lysine] backbone.
    Hudecz F
    Biomed Pept Proteins Nucleic Acids; 1995; 1(4):213-20. PubMed ID: 9346834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera toxin conjugates for intragastric vaccination against herpes simplex virus type 2.
    Drew MD; Estrada AE; Underdown BJ; McDermott MR
    Reg Immunol; 1992; 4(2):79-85. PubMed ID: 1503890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
    Karem KL; Bowen J; Kuklin N; Rouse BT
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A L.E.A.P.S. heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection.
    Goel N; Rong Q; Zimmerman D; Rosenthal KS
    Vaccine; 2003 Oct; 21(27-30):4410-20. PubMed ID: 14505924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunisation against HSV-1 keratitis with a synthetic gD peptide.
    Heiligenhaus A; Wells PA; Foster CS
    Eye (Lond); 1995; 9 ( Pt 1)():89-95. PubMed ID: 7713256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain.
    Zimmerman DH; Lloyd JP; Heisey D; Winship MD; Siwek M; Talor E; Sarin PS
    Vaccine; 2001 Sep; 19(32):4750-9. PubMed ID: 11535326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide library.
    Schellekens GA; Lasonder E; Feijlbrief M; Koedijk DG; Drijfhout JW; Scheffer AJ; Welling-Wester S; Welling GW
    Eur J Immunol; 1994 Dec; 24(12):3188-93. PubMed ID: 7805747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.
    Geerligs HJ; Kocken CH; Drijfhout JW; Weijer WJ; Bloemhoff W; Wilterdink JB; Welling GW; Welling-Wester S
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1767-74. PubMed ID: 2167930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein G of herpes simplex virus type 1: identification of type-specific epitopes by human antibodies.
    Tunbäck P; Liljeqvist JA; Löwhagen GB; Bergström T
    J Gen Virol; 2000 Apr; 81(Pt 4):1033-40. PubMed ID: 10725430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide.
    Chen YS; Hung YC; Lin WH; Huang GS
    Nanotechnology; 2010 May; 21(19):195101. PubMed ID: 20400818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.
    Strynadka NC; Redmond MJ; Parker JM; Scraba DG; Hodges RS
    J Virol; 1988 Sep; 62(9):3474-83. PubMed ID: 2457115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection.
    Chabalgoity JA; Khan CM; Nash AA; Hormaeche CE
    Mol Microbiol; 1996 Feb; 19(4):791-801. PubMed ID: 8820649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.